The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats
Open accessAbstract
The renin-angiotensin system (RAS) is frequently activated in patients with chronic liver diseases. Angiotensin-II (AT-II) has been suggested to play an important role in liver fibrogenesis. It induces hepatic stellate cell (HSC) proliferation and up-regulates the transforming growth factor beta(1) (TGF-beta(1)) expression via AT-II type 1 receptor (AT(1)-R) in vitro. The aim of the present study was to examine the in vivo effect of candesartan (CA), a clinically used AT(1)-R blocker (ARB), and perindopril (PE), an angiotensin-converting enzyme (ACE) inhibitor (ACE-I), on pig serum-induced liver fibrosis development in rats. The clinically available comparable doses of CA and PE significantly attenuated the fibrosis development. These inhibitory effects of PE and CA were also found in the on-going liver fibrosis model. The hepatic hydroxyproline and serum fibrosis markers were significantly suppressed by CA and PE treatment. Furthermore, the alpha smooth muscle actin (alpha-SMA) positive cells in number were markedly suppressed by CA and PE treatment. Similarly, the hepatic TGF-beta(1) protein and messenger RNA (mRNA) levels were significantly suppressed. Our in vitro study showed that AT-II increased the TGF-beta(1) mRNA expression in the activated HSCs, and this effect was totally blocked by CA. These results suggested that the RAS, especially AT-II and AT(1)-R interaction plays a pivotal role in liver fibrosis development through HSC activation. Because both CA and PE are widely used in clinical practice without serious side effects, these drugs may provide an effective new strategy for anti-liver fibrosis therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kagami, S., Border, W. A., Miller, D. E., & Noble, N. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117251 · Cited by 1,076
Singh, K. D., & Karnik, S. S. (2020) · GPCRs · doi:10.1016/b978-0-12-816228-6.00020-9 · Cited by 704
Angiotensin II induces contraction and proliferation of human hepatic stellate cells
Bataller, R., Ginès, P., Nicolás, J. M., Görbig, M. N., Garcia–Ramallo, E., Gasull, X., Bosch, J., Arroyo, V., & Rodés, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70368-4 · Cited by 490
Rockey, D. C., & Weisiger, R. A. (1996) · Hepatology · doi:10.1002/hep.510240137 · Cited by 385
Role of Vegf-Flt Receptor System in Normal and Tumor Angiogenesis
(1995) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60716-2 · Cited by 323
Mise, M., Arii, S., Higashituji, H., Furutani, M., Niwano, M., Harada, T., Ishigami, S., Toda, Y., Nakayama, H., Fukumoto, M., et al. (1996) · Hepatology · doi:10.1002/hep.510230309 · Cited by 307
Williams, B., Baker, A. Q., Gallacher, B., & Lodwick, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.913 · Cited by 301
Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats
Yasuda, M., Shimizu, I., Shiba, M., & Ito, S. (1999) · Hepatology · doi:10.1002/hep.510290307 · Cited by 283
Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo.
Rockey, D. C., Housset, C. N., & Friedman, S. L. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116769 · Cited by 268
Yoshiji, H., Kuriyama, S., Miyamoto, Y., Thorgeirsson, U. P., Gomez, D. E., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Tsujinoue, H., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.20521 · Cited by 252
Self-citationBIOLOGICAL FUNCTIONS OF ANGIOTENSIN AND ITS RECEPTORS
Matsusaka, T., & Ichikawa, I. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.395 · Cited by 224
Yoshiji, H., Kuriyama, S., Kawata, M., Yoshii, J., Ikenaka, Y., Noguchi, R., Nakatani, T., Tsujinoue, H., & Fukui, H. (2001) · PubMed · Cited by 211
Self-citationAngiotensin II Is Mitogenic for Human Lung Fibroblasts via Activation of the Type 1 Receptor
MARSHALL, R. P., McANULTY, R. J., & LAURENT, G. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.6.9907004 · Cited by 207
Rosmorduc, O., Wendum, D., Corpechot, C., Galy, B., Sebbagh, N., Raleigh, J., Housset, C., & Poupon, R. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65209-1 · Cited by 205
Effect of Losartan, An Angiotensin Ii Receptor Antagonist, on Portal Pressure in Cirrhosis
Schneider, A. W., Kalk, J. F., & Klein, C. P. (1999) · Hepatology · doi:10.1002/hep.510290203 · Cited by 198
Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
Dzau, V. J., Gibbons, G. H., & Pratt, R. E. (1991) · Hypertension · doi:10.1161/01.hyp.18.4_suppl.ii100 · Cited by 191
Yoshiji, H., Kuriyama, S., Ways, D. K., Yoshii, J., Miyamoto, Y., Kawata, M., Ikenaka, Y., Tsujinoue, H., Nakatani, T., Shibuya, M., et al. (1999) · PubMed · Cited by 183
Self-citationAnkoma-Sey, V., Wang, Y., & Dai, Z. (2000) · Hepatology · doi:10.1002/hep.510310122 · Cited by 179
Sakaida, I., Tsuchiya, M., Kawaguchi, K., Kimura, T., Terai, S., & Okita, K. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00094-1 · Cited by 176
Angiotensin II Activates Collagen I Gene Through a Mechanism Involving the MAP/ER Kinase Pathway
Tharaux, P.-L., Chatziantoniou, C., Fakhouri, F., & Dussaule, J.-C. (2000) · Hypertension · doi:10.1161/01.hyp.36.3.330 · Cited by 173
Arroyo, V., Bosch, J., Mauri, M., Ribera, F., Navarro-López, F., & Rodés, J. (1981) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1981.tb01844.x · Cited by 153
Gautschi, O. P., Tschopp, S., Olie, R. A., Leech, S. H., Simões‐Wüst, A. P., Ziegler, A., Baumann, B., Odermatt, B. F., Hall, J., Stahel, R. A., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.6.463 · Cited by 145
Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis
Arthur, M. J. P., Mann, D. A., & Iredale, J. P. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.1998.13.s1.33 · Cited by 138
Ballet, F., Chrétien, Y., Rey, C., & Poupon, R. Y. (1987) · Journal of Hepatology · doi:10.1016/s0168-8278(87)80253-2 · Cited by 109
Chow, N.-H., Hsu, P.-I., Lin, X., Yang, H., Chan, S.-H., Cheng, K., Huang, S.-M., & Su, I. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90179-9 · Cited by 108
Helmy, A., Jalan, R., Newby, D. E., Hayes, P. C., & Webb, D. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70263-0 · Cited by 107
Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor β1
Danielpour, D. (1993) · Journal of Immunological Methods · doi:10.1016/0022-1759(93)90254-5 · Cited by 104
Sakaida, I., Matsumura, Y., Kubota, M., Kayano, K., Takenaka, K., & Okita, K. (1996) · Hepatology · doi:10.1002/hep.510230416 · Cited by 97
Yoshiji, H., Kuriyama, S., Hicklin, D. J., Huber, J., Yoshii, J., Miyamoto, Y., Kawata, M., Ikenaka, Y., Nakatani, T., Tsujinoue, H., et al. (1999) · Hepatology · doi:10.1002/hep.510300509 · Cited by 94
Self-citationWang, Y. Q., Ikeda, K., Ikebe, T., Hirakawa, K., Sowa, M., Nakatani, K., Kawada, N., & Kaneda, K. (2000) · Hepatology · doi:10.1053/jhep.2000.18658 · Cited by 74
Roth, S., Michel, K., & Gressner, A. M. (1998) · Hepatology · doi:10.1002/hep.510270416 · Cited by 72
Ishigai, Y., Mori, T., Ikeda, T., Fukuzawa, A., & Shibano, T. (1997) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1997.273.6.h2659 · Cited by 71
長尾, 美., Nakajima, Y., Kanehiro, H., Hisanaga, M., Aomatsu, Y., Ko, S., Tatekawa, Y., Ikeda, N., Kanokogi, H., Urizono, Y., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.16470 · Cited by 62
Sakaida, I., Uchida, K., Matsumura, Y., & Okita, K. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80322-x · Cited by 52
Eickhoff, B., Rüller, S., Laue, T., Köhler, G., Stahl, C., Schlaak, M. S., & van der Bosch, J. (2000) · Biological Chemistry · doi:10.1515/bc.2000.015 · Cited by 50
Cited by
Roles of TGF-beta in hepatic fibrosis
Gressner, A. M. (2002) · Frontiers in Bioscience · doi:10.2741/a812 · Cited by 783
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
Lonardo, A., Nascimbeni, F., Mantovani, A., & Targher, G. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.09.021 · Cited by 736
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Bataller, R., Sancho-bru, P., Ginès, P., Lora, J. M., Al-garawi, A., Solé, M., Colmenero, J., Nicolás, J. M., Jiménez, W., Weich, N., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00695-4 · Cited by 352
Nonalcoholic Fatty Liver Disease: A Review and Update
Lewis, J. R., & Mohanty, S. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-1081-0 · Cited by 345
Metadata
- Authors
- YOSHIJI, H., KURIYAMA, S., YOSHII, J., IKENAKA, Y., NOGUCHI, R., NAKATANI, T., TSUJINOUE, H., & FUKUI, H.
- Venue
- Hepatology
- Published
- 2001-10
- Volume
- 34
- Issue
- 4
- Pages
- 745-750
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W1994733930
- Cited by
- 397
- References
- 35
- FWCI
- 13.69
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.